BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 37257234)

  • 1. Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race.
    Frediani JK; Pak-Harvey E; Parsons R; Westbrook AL; O'Sick W; Martin GS; Lam WA; Levy JM
    Blood Cells Mol Dis; 2023 Sep; 102():102756. PubMed ID: 37257234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M
    Hemoglobin; 2021 Nov; 45(6):371-379. PubMed ID: 34027786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Boğa C; Asma S; Leblebisatan G; Şen N; Tombak A; Demiroğlu YZ; Yeral M; Akın Ş; Yeşilağaç H; Habeşoğlu MA; Arıboğan A; Kasar M; Korur A; Özdoğu H
    Ann Hematol; 2021 Sep; 100(9):2195-2202. PubMed ID: 34032899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Varelas C; Gavriilaki E; Sakellari I; Klonizakis F; Anagnostopoulos A; Tsapas A; Vlachaki E
    Hemoglobin; 2022 Mar; 46(2):143-145. PubMed ID: 36100258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accounting for Social Risk Does not Eliminate Race/Ethnic Disparities in COVID-19 Infection Among Insured Adults: a Cohort Study.
    McCloskey JK; Ellis JL; Uratsu CS; Drace ML; Ralston JD; Bayliss EA; Grant RW
    J Gen Intern Med; 2022 Apr; 37(5):1183-1190. PubMed ID: 35107716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
    Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
    JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
    Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
    Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.
    Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB
    JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
    Taher AT; Bou-Fakhredin R; Kreidieh F; Motta I; De Franceschi L; Cappellini MD
    Am J Hematol; 2020 Aug; 95(8):E208-E210. PubMed ID: 32394480
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2.
    Elia GM; Konstantyner T; Nais RP; Santos ARAD; Angel A; Braga JAP
    Rev Paul Pediatr; 2023; 41():e2021407. PubMed ID: 36921171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of nasopharyngeal swab collection and positivity for SARS-CoV-2 infection in the population of the Italian province of Udine with and without chronic conditions.
    Valent F; Mazzilis G; Doimo A; Pipan C
    Health Policy; 2021 Feb; 125(2):155-159. PubMed ID: 33384183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California.
    Yamaki J; Peled H; Mathews S; Park D; Firoozi M; Smith K; Nguyen L
    J Racial Ethn Health Disparities; 2021 Dec; 8(6):1551-1555. PubMed ID: 33230735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute chest syndrome in the setting of SARS-COV-2 infections-A case series at an urban medical center in the Bronx.
    Morrone KA; Strumph K; Liszewski MJ; Jackson J; Rinke ML; Silver EJ; Minniti C; Davila J; Mitchell WB; Manwani D
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28579. PubMed ID: 32893954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial, ethnic and socioeconomic disparities in SARS-CoV-2 infection amongst children.
    Mannheim J; Konda S; Logan LK
    Paediatr Perinat Epidemiol; 2022 May; 36(3):337-346. PubMed ID: 35076946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.
    Lopes A; Dantas MT; Ladeia AMT
    Arq Bras Cardiol; 2022 Dec; 119(6):893-899. PubMed ID: 36417618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.